Greenlight Capital Bets on Henry Schein, Sees Room for Margin Expansion and Value Creation
In its Q4 2025 letter, Greenlight Capital revealed a new position in dental distributor Henry Schein (HSIC), arguing the stock presents an opportunity for operational improvement and shareholder returns, despite recent underperformance.